Sign In
Buy ISEE
$39.95
+0 (+0%)
At Close: Oct 09, 2023
IVERIC bio Reports First Quarter 2020 Operational Highlights and Financial Results
11:00am, Wednesday, 06'th May 2020
IVERIC bio announced financial and operating results for the fiscal quarter ended March 31, 2020 and provided a general business update.
May 02, 2020 (CDN Newswire via Comtex) --
A recent comprehensive study titled Global Juvenile Macular Degeneration (Stargardt Disease) Treatment Market 2020...
IVERIC bio (NASDAQ:ISEE) Raised to "Buy" at Zacks Investment Research
06:48am, Thursday, 30'th Apr 2020
IVERIC bio (NASDAQ:ISEE) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a note issued to investors on Thursday, Zacks.com reports. The firm presently has a
IVERIC bio to Report First Quarter 2020 Financial Results and Host Conference Call on Wednesday, May 6, 2020
12:00pm, Tuesday, 28'th Apr 2020
IVERIC bio today announced that it will report its first quarter 2020 financial and operating results on Wednesday, May 6, 2020.
IVERIC bio (NASDAQ:ISEE) Downgraded to Hold at Zacks Investment Research
05:56am, Saturday, 18'th Apr 2020
IVERIC bio (NASDAQ:ISEE) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Saturday, Zacks.com reports. According to
IVERIC bio announced that the U.S. FDA has granted Fast Track designation to Zimura® for the treatment of geographic atrophy secondary to wet AMD.
uniQure to Participate in Multiple Upcoming Investor Conferences in April | MarketScreener
11:01am, Monday, 30'th Mar 2020IVERIC bio Appoints Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer
08:01pm, Monday, 23'rd Mar 2020
IVERIC bio, Inc. announced the appointment of Pravin U. Dugel, MD, as Executive Vice President and Chief Strategy and Business Officer.
Coronavirus pandemic leads big drugmakers to hit pause on clinical trials
07:29pm, Monday, 23'rd Mar 2020
U.S. drugmakers Eli Lilly and Co and Bristol Myers Squibb said they are delaying...
UPDATE 3-Coronavirus pandemic leads big drugmakers to hit pause on clinical trials
07:23pm, Monday, 23'rd Mar 2020
U.S. drugmakers Eli Lilly and Co and Bristol Myers Squibb said they are delaying...
Coronavirus begins disrupting clinical trials as companies try containing spread
03:39pm, Wednesday, 18'th Mar 2020
U.S.-based Iveric bio Inc delayed enrolment in a trial of its eye disease drug on Wednesday, two days after Provention Bio paused a study of its diabetes drug but allowed trial patients to complete th
UPDATE 2-FDA urges virtual patient visits as coronavirus disrupts clinical trials
03:37pm, Wednesday, 18'th Mar 2020
The U.S. Food and Drug Administration on Wednesday recommended switching to virt...
UPDATE 1-Coronavirus begins disrupting clinical trials as companies try containing spread
01:59pm, Wednesday, 18'th Mar 2020
U.S.-based Iveric bio Inc on Wednesday became the latest company to delay a clin...
U.S. companies begin delaying clinical trials due to coronavirus outbreak
12:51pm, Wednesday, 18'th Mar 2020
U.S.-based Iveric bio Inc on Wednesday became the latest company to delay a clin...
IVERIC bio announced that due to the threat of COVID-19, the Company decided to delay enrollment in the second pivotal clinical trial for Zimura®.
